Affimed N V (AFMD) Return on Investment ROI from the second quarter of 2024 to second quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Affimed N v   (NASDAQ: AFMD)


Affimed N V's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Affimed N V's ROI in the second quarter of 2024?
Affimed N V recorded a cumulative net loss of $-167 million during 12 months ending in the second quarter of 2024, resulting in a negative return on investment (ROI) of -286.79%.

Within the Healthcare sector 848 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2023 from 4542 to 5346.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2024)
II. Quarter		 (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Investment Change TTM -60.39 % -63.32 % -48.86 % -32.3 % -21.23 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 39 65 65 65 65
Return On Investment (TTM) -286.79 % -232.7 % -140.44 % -106.39 % -79.45 %
AFMD's Overall Ranking # 5346 # 4542 # 0 # 0 #
Seq. Investment Change TTM -9.9 % -29.14 % -24.25 % -18.08 % -16.57 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -167 -151 -128 -128 -117

AFMD Company Profile >> Back to AFMD Roi Comparisons >> See Annual AFMD Return On Investment



Return On Investment AFMD's Ranking
Within: No.
Industry # 406
Sector # 849
Overall # 5346

Return On Investment Statistics
High Average Low
-24.55 %
-63.31 %
-183.26 %
(Dec 31 2018)   (Dec 31 2023)



  News about Affimed N v Return on Investment ROI

Affimed N.V. Sells Wholly-Owned Subsidiary AbCheck and Works Towards Growth Opportunities in Cancer Immunotherapy

January 3, 2024


The announcement follows Affimed s listing transfer to the Nasdaq Capital Market in October 2023, which was seen as a strategic move to unlock new growth opportunities. The transfer, effective from October 4, 2023, allows Affimed to be among a broader range of growth-oriented businesses, providing increased visibility and accessibility to institutional and retail investors





Financial Statements
Affimed N V's II. Quarter Investments $ 39 Millions AFMD's Balance sheet
Affimed N V's II. Quarter Income $ -17 Millions Quarterly AFMD's Income Statement
AFMD's Income by Division See AFMD's Income by Division


AFMD Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 65 171 180 122 86
Y / Y Investment Growth -62.2 % -4.78 % 47.74 % 40.84 % -2.71 %
Net Income in Millions -119 -96 -64 -46 -36
Y / Y Net Income Growth - - - - -
Annual Return On Investment -183.26 % -56.24 % -35.82 % -38.06 % -41.94 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AFMD's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AFMD's Competitors
Subscribers only: Roi for Affimed N V's Suppliers
Subscribers only: Return On Investment for AFMD's Customers

Other Ratios
AFMD's Roa AFMD's Inventory Turnover Ratio AFMD's Growth Rates AFMD's Dividend Statistics
AFMD's Profitability Ratios AFMD's Asset Turnover Ratio AFMD's Dividend Growth
AFMD's Roe AFMD's Valuation Ratios AFMD's Financial Strength Ratios AFMD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-18T15:15:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.